Does CANRENOATE Cause Hepatic function abnormal? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic function abnormal have been filed in association with CANRENOATE. This represents 1.1% of all adverse event reports for CANRENOATE.
5
Reports of Hepatic function abnormal with CANRENOATE
1.1%
of all CANRENOATE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatic function abnormal From CANRENOATE?
Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANRENOATE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CANRENOATE Cause?
Hyperkalaemia (96)
Acute kidney injury (63)
Toxic epidermal necrolysis (58)
Hyponatraemia (52)
Off label use (45)
Dehydration (39)
Hypotension (39)
Drug hypersensitivity (37)
Dyspnoea (36)
Asthenia (33)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which CANRENOATE Alternatives Have Lower Hepatic function abnormal Risk?
CANRENOATE vs CANRENOIC ACID
CANRENOATE vs CANRENONE
CANRENOATE vs CANTHARIDIN
CANRENOATE vs CAPECITABINE
CANRENOATE vs CAPIVASERTIB